CLINICAL ROLE -
New Law Promotes Development of and Access to New Diagnostic Tests
Congress has passed a law designed to get advanced diagnostic tests to patients more quickly and to promote personalized care for patients.
Read More
Making the Marketplace More Patient Focused
As the administration looks at improving the insurance marketplace, patient advocates are developing a wish list of modifications to ensure that it is more patient focused.
Understanding the Actual Cost of Health Insurance
People with chronic conditions need effective and affordable drugs to live longer and better lives. Unfortunately, regulations covering plans in state exchanges may impede access.
Exchange Formularies: Cracks in the Coverage
How to Systematically Capture Meaningful Patient Input
A tool for organizing patient concerns and comments to ensure that the FDA captures the comprehensive information it needs to integrate patient perspectives throughout the agency's review process.
Establishing Usability Criteria to Maximize Value of CER
Usability criteria will help investigators structure CER to answer the questions that are most important to patients, their family caregivers, healthcare providers, and policy makers.
Articulating Patient Involvement in FDA Regulatory Reviews
Use of a simple model developed by the patient advocacy community could facilitate valuable dialogue between the FDA and people with chronic conditions.
HIPAA Privacy Rule: Impeding Research and New Cures
In the interest of advancing research for new treatments and cures, problems in the HIPAA privacy rule must be addressed by all health community stakeholders.
Healthcare Reform and the Supreme Court
As the Supreme Court nears its decision on the constitutionality of ACA, healthcare reform is already pushing inexorably forward.
Developing a Learning Healthcare System
Two initiatives currently under way will support the generation of new insight into the safety of medicines and treatment effectiveness.
Developing a Global Strategy to Combat Noncommunicable Diseases
WHO'S commitment to addressing the impact of 4 common noncommunicable diseases will ultimately lead to improvements for patients with a broad range of chronic conditions.
A New Paradigm for Accelerating the Search for New Cures
A bill introduced in the US House of Representatives, the MODDERN Cures Solution, would ensure that science, not patent law, drives development of new therapies.
Essential Health Benefits, Part 2
This is the second of a 2-part series on the development of the essential health benefit package prescribed under the Patient Protection and Affordable Care Act.